Sarepta Therapeutics (SRPT) Operating Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.25% |
| Dec 31, 2025 | -19.24% |
| Sep 30, 2025 | 5.48% |
| Jun 30, 2025 | 23.17% |
| Mar 31, 2025 | -20.54% |
| Dec 31, 2024 | 22.00% |
| Sep 30, 2024 | 16.86% |
| Jun 30, 2024 | 69.72% |
| Mar 31, 2024 | 19.70% |
| Dec 31, 2023 | 16.83% |
| Sep 30, 2023 | 21.54% |
| Jun 30, 2023 | -5.24% |
| Mar 31, 2023 | -35.05% |
| Dec 31, 2022 | -35.78% |
| Sep 30, 2022 | -23.40% |
| Jun 30, 2022 | -27.23% |
| Mar 31, 2022 | -17.23% |
| Dec 31, 2021 | -3.66% |
| Sep 30, 2021 | 9.43% |
| Jun 30, 2021 | -21.96% |
| Mar 31, 2021 | -20.53% |
| Dec 31, 2020 | -21.51% |
| Sep 30, 2020 | -21.50% |
| Jun 30, 2020 | -26.86% |
| Mar 31, 2020 | -13.79% |
| Dec 31, 2019 | -38.78% |
| Sep 30, 2019 | -29.70% |
| Jun 30, 2019 | -55.52% |
| Mar 31, 2019 | -24.91% |
| Dec 31, 2018 | -33.51% |
| Sep 30, 2018 | -22.97% |
| Jun 30, 2018 | -43.35% |
| Mar 31, 2018 | -14.80% |
| Dec 31, 2017 | -17.43% |
| Sep 30, 2017 | -46.06% |
| Jun 30, 2017 | -62.69% |
| Mar 31, 2017 | -41.68% |
| Dec 31, 2016 | -57.92% |
| Sep 30, 2016 | -38.06% |
| Jun 30, 2016 | -43.73% |
| Mar 31, 2016 | -60.93% |
| Dec 31, 2015 | -105.94% |
| Sep 30, 2015 | -68.62% |
| Jun 30, 2015 | -40.59% |